We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Screening Strategies in Drug Discovery – News and Features

News

Akubio Announces Appointment of Business Development Director

Ian Campbell has been appointed as Business Development Director.
News

Axxam Provides Screening Assays to NIH Chemical Genomics Centre

NIH will use these assays in the screening campaigns within the Molecular Libraries Roadmap Initiative.
News

Athersys Extends Partnership with Bristol-Myers to Provide Drug Targets

Athersys will provide RAGE technology to Bristol-Myers Squibb with additional validated drug targets for high-throughput screening.
News

DNAPrint Completes Acquistion of Ellipsis Biotherapeutics

Ellipsis Biotherapeutics acquisition strengthens DNAPrint’ position in the diagnostic and clinical patient testing market.
News

The Scripps Research Institute Adopts MDL Informatics Applications to Support Research for NIH Program

Scientists to manage high-throughput molecular screening data with MDL® Assay Explorer ® and other MDL technology in nationwide collaboration pursuing medical breakthroughs.
News

Global Expansion of Genedata’s Screening Analysis Collaboration with Roche

The multi-year expansion of the collaboration will include all Roche high HTS facilities in North America and Europe.
News

TransTech Pharma Selects Genedata to Enhance High Throughput Screening Analysis

Scientists at TransTech Pharma will use Screener to enhance their efforts to develop small molecules as therapeutics.
News

Applied Precision Signs OEM and Distribution Agreement with Cellomics

Applied Precision will exclusively supply the cellWoRx imaging scanner to Cellomics.
News

Galapagos Extends Its Collaboration with Amgen Throughout 2006

Galapagos' service division BioFocus will continue to provide Amgen with drug discovery expertise.
News

BioTrove and SPRI Expand Lead Discovery Collaboration

BioTrove will use its RapidFire® Lead Discovery service for assay development and high throughput screening.
Advertisement